goserelin 10.8 MG Drug Implant [Zoladex]
- RxCUI
- 211544
- RxNorm name
- goserelin 10.8 MG Drug Implant [Zoladex]
- Display name
- goserelin 10.8 MG Drug Implant [Zoladex]
- Full name
- goserelin 10.8 MG Drug Implant [Zoladex]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:25
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZOLADEX | GOSERELIN | TerSera Therapeutics LLC | e4cb3c20-2738-400a-b522-3f36f71fe6c5 | 2026-03-24 | Warnings, Adverse reactions | 211544 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e4cb3c20-2738-400a-b522-3f36f71fe6c5 | Zoladex 10.8 MG Subcutaneous Drug Implant [PSN] · goserelin 10.8 MG Drug Implant [Zoladex] [SBD] · Zoladex 10.8 MG Drug Implant [SY] | 3 | 8 | These highlights do not include all the information needed to use ZOLADEX safely and effectively. See full prescribing information for ZOLADEX. ZOLADEX ® (goserelin implant) 10.8 mg Initial U.S. Approval: 1996 | 20260324 |